Deerfield Management Company »

Adma Biologics shares owned by Deerfield Management Company

Quarter-by-quarter ownership of Adma Biologics (ADMA) shares owned by Deerfield Management Company from 13F filings

Historical chart of Deerfield Management Company investment in Adma Biologics

Tip: Access up to 7 years of quarterly data

All positions including Adma Biologics held by Deerfield Management Company consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Adma Biologics by Deerfield Management Company

Quarter filed Position value Share count Share price at filing
2024-09-30 $940k 47k 19.99
2024-06-30 $662k 59k 11.18
2024-03-31 $536k 81k 6.60
2023-12-31 $193k 43k 4.52

More positions owned by Deerfield Management Company

Nuvalent Inc-a (NUVL)
Viatris (VTRS)
Integra Lifesciences Hldgs C Note 0.500% 8/1 (Principal)
Centene Corporation (CNC)
Oscar Health Cl A (OSCR)
Revolution Medicines (RVMD)
Merus N V (MRUS)
Accolade Note 0.500% 4/0 (Principal)
Waystar Holding Corp (WAY)
Neurocrine Biosciences (NBIX)
Alnylam Pharmaceuticals Note 1.000% 9/1 (Principal)
Silverback Therapeutics (SPRY)
Newamsterdam Pharma Company Ordinary Shares (NAMS)
Indivior Ord (INDV)
Mirum Pharmaceuticals Note 4.000% 5/0 (Principal)

View all positions for Deerfield Management Company

Top funds holding Adma Biologics

BlackRock
Vanguard Group
State Street Corporation
Invesco
Morgan Stanley
Geode Capital Management
Dimensional Fund Advisors
Nuveen Asset Management
Deutsche Bank Aktiengesellschaft
American Century Companies
Renaissance Technologies
Perpetual
Oberweis Asset Management
FMR
D. E. Shaw & Co

View all funds holding Adma Biologics